RHH646 clinical trials

A randomized, placebo controlled, investigator and participant-blinded study, investigating safety, tolerability and efficacy of RHH646 in participants with knee osteoarthritis

This study is looking at a new medicine called RHH646 for people with knee osteoarthritis. Researchers want to see if it's safe, if people can tolerate it well, and if it helps by checking changes in knee cartilage over 52 weeks.